Anti-phospholipid antibodies are associated with response to interferon-beta1a treatment in MS: results from a 3-year longitudinal study.
about
Demyelinating and thrombotic diseases of the central nervous system: common pathogenic and triggering factors.Aspirin and multiple sclerosisHughes syndrome and multiple sclerosis.High frequency of antiphospholipid antibodies in relapse of multiple sclerosis: a possible indicator of inflammatory–thrombotic processes
P2860
Anti-phospholipid antibodies are associated with response to interferon-beta1a treatment in MS: results from a 3-year longitudinal study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Anti-phospholipid antibodies a ...... m a 3-year longitudinal study.
@en
Anti-phospholipid antibodies a ...... m a 3-year longitudinal study.
@nl
type
label
Anti-phospholipid antibodies a ...... m a 3-year longitudinal study.
@en
Anti-phospholipid antibodies a ...... m a 3-year longitudinal study.
@nl
prefLabel
Anti-phospholipid antibodies a ...... m a 3-year longitudinal study.
@en
Anti-phospholipid antibodies a ...... m a 3-year longitudinal study.
@nl
P2093
P2860
P50
P1476
Anti-phospholipid antibodies a ...... m a 3-year longitudinal study.
@en
P2093
Alireza Minagar
Deepa P Ramasamy
Julian Ambrus
Niels Bergsland
Sara Hussein
P2860
P304
P356
10.1179/1743132812Y.0000000076
P577
2012-10-01T00:00:00Z